CSL Stock Forecast for 2023 - 2025 - 2030

Updated on 02/21/2024

Stock Rating
12
Price Target
$202.63
Consensus
Outperform
Downside
-27.90%
Analysts
5
Stock Rating
12
Downside
-27.90%
Analysts
5
Price Target
$202.63

CSL Stock Forecast and Price Target

According to five experts, who recently provided their 2024 price targets for CSL, the average price target is $202.63, with a high estimate of $221.26 and a low estimate of $164.30. That is a potential downside of approximately -27.9% from the last closing price of $281.03 on February, 2024. Even if not interested in CSL stock, you may want to be aware of its competitors.

$202.63

-27.90% Downside

Outperform
Outperform

CSL Fair Value Forecast for 2023 - 2025 - 2030

CSL's Price has decreased In the last four years, from $254.10 to $0.00 – a 100.00% drop. Analysts predict that CSL's Fair Value will increase in the upcoming year, reaching $337.15. This would represent an increase of 100.00%. Over the next seven years, experts predict that CSL's Fair Value will grow at a rate of 100.00%.

2024 Fair Value Forecast
$337.15
2025 Fair Value Forecast
$393.80
2026 Fair Value Forecast
$464.20
2027 Fair Value Forecast
$525.80
2028 Fair Value Forecast
$579.15
2029 Fair Value Forecast
$663.30
2030 Fair Value Forecast
$709.50
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
NOVO B Stock Forecast Novo Nordisk A/S Outperform 12
kr858.00 Buy/Sell kr696.07 -6.76%
JNJ Stock Forecast Johnson & Johnson Outperform 9
$156.55 Buy/Sell $174.55 9.23%
MRK Stock Forecast Merck Outperform 2
$127.79 Buy/Sell $130.51 5.64%
NOVN Stock Forecast Novartis Outperform 10
CHF89.56 Buy/Sell CHF105.00 19.79%
ABT Stock Forecast Abbott Laboratories Outperform 9
$114.01 Buy/Sell $118.92 10.52%

CSL Revenue Forecast for 2023 - 2025 - 2030

In the last three years, CSL's Revenue has seen an increase, rising from $9.15B to $13.31B. This represents a growth of 45.45%. Analysts predict that CSL's Revenue will increase in the upcoming year, reaching $14.76B. This would represent an increase of 10.89%. Over the next seven years, experts predict that CSL's Revenue will grow at a rate of 86.54%.

2024 Rev Forecast
$14.76B
2025 Rev Forecast
$16.07B
2026 Rev Forecast
$17.31B
2027 Rev Forecast
$18.77B
2028 Rev Forecast
$20.54B
2029 Rev Forecast
$23.42B
2030 Rev Forecast
$24.83B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
AZN Stock Forecast AstraZeneca PLC Outperform 17
£104.18 Buy/Sell £165.99 52.48%
PFE Stock Forecast Pfizer Outperform 2
$27.62 Buy/Sell $32.87 12.24%
SAN Stock Forecast Sanofi Outperform 16
86.22€ Buy/Sell 102.80€ 24.10%

CSL Dividend per Share Forecast for 2023 - 2025 - 2030

CSL's Dividend per Share has seen growth In the last three years, going from $2.02 to $2.36 – a gain of 16.83% In the next year, analysts believe that Dividend per Share will reach $2.65 – an increase of 12.29%. For the next seven years, the forecast is forDividend per Share to grow by 140.68%.

2024 DPS Forecast
$2.65
2025 DPS Forecast
$3.01
2026 DPS Forecast
$3.59
2027 DPS Forecast
$4.29
2028 DPS Forecast
$4.72
2029 DPS Forecast
$5.31
2030 DPS Forecast
$5.68
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
VRTX Stock Forecast Vertex Pharmaceuticals Inc Outperform 12
$422.20 Buy/Sell $457.70 6.58%
GILD Stock Forecast Gilead Sciences Inc Outperform 11
$71.58 Buy/Sell $89.97 24.34%
GSK Stock Forecast GSK Outperform 12
£16.69 Buy/Sell £17.30 10.25%

CSL Free Cash Flow Forecast for 2023 - 2025 - 2030

2024 FCF Forecast
$2.33B
2025 FCF Forecast
$3.07B
2026 FCF Forecast
$3.56B
2027 FCF Forecast
$4.24B
2028 FCF Forecast
$4.66B
2029 FCF Forecast
$4.97B
2029 FCF Forecast
$4.97B
2030 FCF Forecast
$5.34B
2030 FCF Forecast
$5.34B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
4502 Stock Forecast Takeda Pharmaceutical Company Outperform 5
¥4.44k Buy/Sell ¥4.74k 3.72%
BIIB Stock Forecast Biogen Outperform 10
$219.08 Buy/Sell $312.80 36.94%
BAYN Stock Forecast Bayer Hold 5
28.90€ Buy/Sell 45.15€ 45.33%

CSL EBITDA Forecast for 2023 - 2025 - 2030

CSL's EBITDA has grown in the last three years, jumping from $3.00B to $3.88B – an increase of 29.38%. In the next year, analysts predict that EBITDA will reach $4.92B – an increase of 26.90%. For the next eight years, the forecast is for EBITDA to grow by 115.02%.

2024 EBITDA Forecast
$4.92B
2025 EBITDA Forecast
$5.55B
2026 EBITDA Forecast
$6.26B
2027 EBITDA Forecast
$7.01B
2028 EBITDA Forecast
$7.63B
2029 EBITDA Forecast
$8.33B
2030 EBITDA Forecast
$8.33B
2030 EBITDA Forecast
$8.33B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BAX Stock Forecast Baxter International Inc Outperform 17
$41.22 Buy/Sell $44.86 6.74%
4503 Stock Forecast Astellas Pharma Outperform 18
¥1.68k Buy/Sell ¥2.64k 42.64%
UCB Stock Forecast UCB Outperform 18
95.40€ Buy/Sell 102.66€ 4.82%

CSL EBIT Forecast for 2023 - 2025 - 2030

In the last three years, CSL's EBIT has increased by 19.75%, going from $2.72B to $3.25B. In the next year, analysts are expecting an increase in EBIT, predicting it will reach $4.19B – an increase of 28.82%. The CSL forecast is for EBIT to reach $7.86B or grow by 141.58%.

2024 EBIT Forecast
$4.19B
2024 EBIT Forecast
$4.19B
2025 EBIT Forecast
$4.79B
2025 EBIT Forecast
$4.79B
2026 EBIT Forecast
$5.50B
2027 EBIT Forecast
$6.16B
2028 EBIT Forecast
$6.73B
2029 EBIT Forecast
$7.39B
2030 EBIT Forecast
$7.86B
2030 EBIT Forecast
$7.86B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
SOBI Stock Forecast Swedish Orphan Biovitrum AB (p... Buy 16
kr260.00 Buy/Sell kr293.00 24.04%
GRF Stock Forecast Grifols Outperform 18
10.97€ Buy/Sell 18.48€ 80.04%
600161 Stock Forecast Beijing Tiantan Biological Pro... Buy 18
¥28.08 Buy/Sell ¥31.28 9.97%

CSL EPS Price Prediction Forecast for 2023 - 2025 - 2030

CSL's EPS has decreased In the last four years, from $4.62 to $0.00 – a 100.00% drop. Analysts predict that CSL's EPS will increase in the upcoming year, reaching $6.13. This would represent an increase of 100.00%. Over the next seven years, experts predict that CSL's EPS will grow at a rate of 100.00%.

2024 EPS Forecast
$6.13
2025 EPS Forecast
$7.16
2026 EPS Forecast
$8.44
2027 EPS Forecast
$9.56
2028 EPS Forecast
$10.53
2029 EPS Forecast
$12.06
2030 EPS Forecast
$12.90
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
002252 Stock Forecast Shanghai RAAS Blood Products Buy 18
¥6.96 Buy/Sell ¥9.08 15.52%
002007 Stock Forecast Hualan Biological Engineering Outperform 18
¥19.08 Buy/Sell ¥25.89 43.61%
BIOCON Stock Forecast Biocon Outperform 14
Rp291.05 Buy/Sell Rp270.86 -2.08%